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2686Objectives: Cardiothoracic surgical leadership recently challenged the surgical community to achieve an oper-
ative mortality rate of 1.0% for the performance of isolated coronary artery bypass grafting (CABG). The pos-
sibility of achieving this goal remains unknown due to the increasing number of high-risk patients being referred
for CABG. The purpose of our study was to identify a patient population in which this operative mortality goal is
achievable relative to the estimated operative risk.
Methods: Patient records from a multi-institution (17 centers) Society of Thoracic Surgeons (STS) database for
primary, isolated CABG operations (2001-2012) were analyzed. Multiple logistic regression modeling with
spline functions for calculated STS predicted risk of mortality (PROM) was used to rigorously assess the rela-
tionship between estimated patient risk and operative mortality, adjusted for operative year and surgeon volume.
Results: A total of 34,416 patients (average patient age, 63.9 10.7 years; 27% [n¼ 9190] women) incurred an
operative mortality rate of 1.87%. Median STS predicted risk ofmortality was 1.06% (interquartile range, 0.60%-
2.13%) andmedian surgeonCABGvolumewas 544 (interquartile range, 303-930)operationsover the studyperiod.
After risk adjustment for the confounding influence of surgeon volume and operative year, the association between
STS PROM and operative mortality was highly significant (P<.0001). More importantly, the adjusted spline func-
tion revealed that an STS PROM threshold value of 1.27% correlatedwith a 1.0% probability of death, accounting
for 57.3% (n ¼ 19,720) of the total study population. Further, the STS PROM demonstrated a limited predictive
capacity for operative mortality for STS PROM>25% as observed to expected mortality began to diverge.
Conclusions: Achieving the goal of 1.0% operative mortality for primary, isolated CABG is feasible in appro-
priately selected patients in the modern surgical era. However, this goal may be achieved in only 60% of CABG
patients without other improvements in processes of care. Calculated STS PROM can be used to strongly iden-
tify patients with estimated mortality risk<1.27% to achieve this goal, but it appears limited in its predictive
capacity for those patients with estimated risk>25.0%. These data provide a foundation for further study to
determine if 1.0%mortality for CABG is achievable nationwide. (J Thorac Cardiovasc Surg 2014;148:2686-96)See related commentary on pages 2697-8.Surgical myocardial revascularization with coronary artery
bypass grafting (CABG) remains 1 of the most common op-
erations performed in the United States.1 Over the past fewe Department of Surgery,a University of Virginia, Charlottesville, Va; Insti-
or Health Care Research and Improvement,b Baylor Research Institute and
rtment of Statistical Science, Dallas, Tex; Inova Heart and Vascular Institute,c
Church, Va; and Sentara Heart Hospital,d Norfolk, Va.
res: Authors have nothing to disclose with regard to commercial support.
the 93rd Annual Meeting of The American Association for Thoracic
ry, Minneapolis, Minnesota, May 4-8, 2013.
J. LaPar, Ivan K. Crosby, Alan M. Speir, Jeffrey B. Rich, Irving L. Kron, and
Ailawadi are investigators for theVirginiaCardiac SurgeryQuality Initiative.
d for publication Feb 23, 2014; revisions received June 12, 2014; accepted for
ation June 28, 2014; available ahead of print Aug 22, 2014.
for reprints: Gorav Ailawadi, MD, Department of Surgery, University of
ia, PO Box 800679, Charlottesville, VA 22908 (E-mail: gorav@virginia.edu).
23/$36.00
ht 2014 Published by Elsevier Inc. on behalf of The American Association
acic Surgery
.doi.org/10.1016/j.jtcvs.2014.06.086
The Journal of Thoracic and Cardiovascular Surdecades, the use of CABG for first-line treatment of coro-
nary artery disease has declined as percutaneous coronary
intervention (PCI) technology has advanced.2 Reduced
mortality rates following performance of PCI over CABG
as demonstrated in the SYNTAX trial and other series has
become central to the argument by many proponents for
PCI for coronary disease amenable to both percutaneous
and surgical revascularization despite improved long-term
outcomes favoring CABG.3 Current estimates of mortality
following PCI have been reported at 1%, whereas those
for the performance of isolated CABG are approximately
2%.1,3 As a result, the surgical community was recently
challenged by leadership in the field of cardiothoracic
surgery to achieve a 1% mortality rate or less for the
performance of isolated CABG operations within the next
3 to 5 years.4 Although ambitious, achieving this goal
would not only significantly influence the debate regarding
choice for PCI versus CABG but would also provide for
higher-quality care for hundreds of thousands of US pa-
tients annually.gery c December 2014
Abbreviations and Acronyms
CABG ¼ coronary artery bypass grafting
PCI ¼ percutaneous coronary intervention
PROM ¼ predictive risk of mortality
RCS ¼ restricted cubic spline
STS ¼ Society of Thoracic Surgeons
VCSQI ¼ Virginia Cardiac Surgery Quality
Initiative
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DThe Society for Thoracic Surgeons (STS) maintains a
nationwide database of adult cardiac surgeries performed in
the United States. Representing the largest clinical database
of its kind, the STSNational Cardiac Database provides clini-
cians and researchers the ability to assess risk-adjusted out-
comes for several different cardiac operations, including
isolated CABG. Furthermore, the STS has developed various
riskmodels for cardiac operations that allow for the prediction
of an expected outcome for a patient based on a given set of
risk factors.5,6 Perhaps the most commonly used STS risk
model is that which estimates the predicted risk of mortality
(PROM) for individual patients. Adjusting for the
prevalence of 30 different demographic, clinical, and
operative present-on-admission factors, the STS PROM can
be calculated for an individual patient to determine that pa-
tient’s expected mortality risk.7 The use of the STS PROM
has been validated and widely accepted by the US cardiotho-
racic surgery community as a reliable preoperative metric to
evaluate patient risk.5,8,9 Thus, STS PROM scores should be
able to identify patients with expected mortality rates 1%.
The Virginia Cardiac Surgery Quality Initiative (VCSQI)
is a voluntary group of 17 different cardiac surgery centers,
both academic and private, within the Commonwealth of
Virginia. This group holds quarterly meetings to exchange
and compare de-identified patient information in an effort
to improve cardiac surgical care, quality, and costs. The pri-
mary objective of the organization is to identify quality
improvement opportunities in cases where high cost,
resource intensive, or frequently occurring preventable out-
comesmight occur. Collectively, the VCSQI centers perform
approximately 99% of the cardiac surgeries performed in the
Commonwealth, and each center individually contributes
patient data to the STS National Cardiac Database.
The purpose of our study was to determine if the
challenge to achieve a 1% operative mortality rate for
primary, isolated CABG operations is feasible in the
modern surgical area, to identify in which patient
populations this mortality goal is achievable relative to
estimated operative risk, and to identify patient- and
operation-related risk factors that contribute most to
mortality among patients where goal mortality was deemed
not achievable to discern if certain patients should not be
receiving surgical myocardial revascularization.The Journal of Thoracic and CarMETHODS
This investigation was exempt from formal institutional review board
review at each participating center because it represents a secondary anal-
ysis of the VCSQI data registry with the absence of Health Insurance Porta-
bility and Accountability Act patient identifiers and because the data is
collected for quality analysis and purposes other than research.Patients and Data Acquisition
De-identified patient-level data were obtained from the VCSQI database
for the study period January 1, 2001, through June 30, 2012. All records
included patients undergoing primary, isolated CABG operations (STS
procedure type ‘‘CAB Only’’ and incidence type ‘‘First Cardiovascular
Surgery’’). All CABG procedures represent standard surgical approaches
to surgical myocardial revascularization with and without the use of cardio-
pulmonary bypass support. Patient preoperative risk was assessed by prev-
alence of patient comorbid disease, extent of coronary artery disease,
operative status, and individually calculated STS PROM score.Measured Outcomes
The primary outcomes of interest was the risk-adjusted association be-
tween the probability of death (operative mortality) and STS PROM score
to identify in which patients a predicted probability of death<1% could be
achieved. Secondary outcomes included estimated risk-adjusted associa-
tions between CABG mortality and established patient risk factors used
to calculate the STS PROM score as well as several process of care mea-
sures endorsed by the STS and National Quality Forum. Operative mortal-
ity was defined as all patient deaths occurring during hospitalization as well
those within 30 days of the date of surgery despite discharge status. Stan-
dard STS clinical definitions for all analyzed variables were used.10Statistical Analysis
Descriptive statistics. All statistical analyses were designed to test
the null hypothesis that operative mortality following primary, isolated
CABG would not be significantly associated with calculated STS PROM
score. Study outcomes and data comparisons were established a priori
before data collection. Categorical variables are expressed as standard
group percentages, whereas continuous variables are expressed as either
mean  standard deviation or median (25th, 75th percentile) depending
on overall variable distribution. Descriptive, univariate statistics included
either Pearson c2 or Fisher exact test for categorical variables and either in-
dependent sample single factor analysis of variance for comparisons of nor-
mally distributed data or the Wilcoxon rank sum test for nonnormally
distributed data comparisons. Calculated test statistics were used to derive
all 2-tailed P values with standard statistical significance set to a<0.05.
Estimated mortality risk and surgeon volume measure-
ment. STS PROM was analyzed as a continuous function, using
restricted cubic spline (RCS) smoothing transformations to account for
both linear and nonlinear associations with operative mortality. RCS func-
tions are beneficial because they use all data points to estimate the shape of
the relationship between an exposure (STS PROM) and an outcome (oper-
ative mortality). The use of RCS transformations, therefore, provides a
more robust method to determine if nonlinear relationships exist between
a continuous variable and a dependent outcome. Use of RCS forces the tails
of a function to be linear, which simplifies the representation. In these an-
alyses, an RCS function was developed for both STS PROM and individual
surgeon volume using a total of three knots placed at the 5th, 50th, and 95th
percentiles of the distribution of both STS PROM and surgeon volume to
define the tails of each function.
Hierarchical regression models. Hierarchical multiple regres-
sion models were used to estimate confounder-adjusted associations be-
tween calculated STS PROM score and the probability of operative
mortality for patients undergoing primary, isolated CABG operations. Indiovascular Surgery c Volume 148, Number 6 2687
TABLE 1. Frequency of select patient risk factors used to estimate
Society of Thoracic Surgeons predicted risk of mortality (STS PROM)
Variable Result %
Operative mortality 666 1.9
Median STS PROM,% 1.1 (0.6, 2.1)
Surgeon volume 544 (303, 930)
Age, y 63.9  12.2
Gender
Male 25,226 73.3
Female 9190 26.7
Weight, kg 86 (75, 99)
Height, cm 173 (165, 180)
Diabetes 13,540 39.3
Dialysis 831 2.4
Chronic lung disease
Mild 3416 9.9
Moderate 1788 5.2
Severe 863 2.5
Immunosuppression 685 2.0
Peripheral vascular disease 4934 14.3
Cerebrovascular disease 4616 13.4
Cerebrovascular accident 1920 5.6
Myocardial infarction 7576 22.0
Heart failure 4071 11.8
New York Heart Association
functional class
I 1622 4.7
II 5961 17.3
III 9665 28.1
IV 3873 11.3
Atrial fibrillation 1385 4.0
Number of diseased vessels
One 1407 4.1
Two 26,782 77.8
Three 6155 17.9
Ejection fraction,% 55 (45, 60)
Status
Elective 13,921 40.4
Urgent 19,288 56.0
Emergent 1207 3.5
Values are given as n, median (25th, 75th percentile), mean standard deviation. STS
PROM, Society of Thoracic Surgeons predicted risk of mortality.
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Daddition, similar models were used to estimate the relative predictive ca-
pacity of established patient- and operation-level risk factors on the prob-
ability of death among 2 different study cohorts based on an identified
threshold value for STS PROM at which the probability of death is<1%
to identify which factors appear to influence mortality the greatest in those
where goal mortality is deemed achievable.
Hierarchical multiple regressionmodels were used to account for poten-
tially overdispersed variance estimates associated with correlated events
within hospitals. Use of such multilevel models has been shown to avoid
overestimation of the statistical significance of association between
modeled covariates, such as STS PROM or surgeon volume, compared
with the use of conventional statistical modeling technique. Clustering at
the hospital level was considered in the hierarchical structure of each logis-
tic regression model to account for the potential confounding influence of
differences in individual hospitals (eg, differences in hospital volume).
Model covariates were selected a priori and were considered potential con-
founders for the influence of STS PROM on patient death. Performed
models for the association between estimated patient risk and the depen-
dent outcome of operative mortality were adjusted for the potential con-
founding influence of individual surgeon experience on patient outcomes
by inclusion of surgeon operative volume during the study period as well
as the influence of baseline changes in practice over the study period by in-
clusion of operative year. Confounder-adjusted measures of association are
reported with a 95% confidence interval for all regression models.
Model parameter significance. The statistical significance of the
association between STS PROM and operative mortality was measured us-
ing 2 different tests. The overall statistical significance of the relationship
between STS PROM and mortality was measured using the nested model
log-likelihood test, which compares the total log-likelihood obtained by
the model to that obtained by an otherwise identical model, excluding the
STS PROM measure. The difference in model log-likelihood yields a test
statistic with a c2 distribution with degrees of freedom equal to the number
of parameters associated with the volume measure. The statistical signifi-
cance of each STSPROMmeasure term in themodels and terms for all other
model factors for each of the fixed effects included in the models was as-
sessed using the factorsmodel effect size or likelihood ratio (Wald statistic).
The likelihood ratio obtained for eachmodeled factorwas used to determine
the relative predictive strength of each factor onmortality risk. Relative dif-
ferences in the overall contribution of each factor to the prediction of mor-
tality in each study cohort was assessed by plotting the likelihood ratios.
Model performance. Model performance was assessed using the C
statistic and the Nagelkerke PseudoR2 statistic. TheC statistic is equivalent
to the area under the receiver operating characteristic curve for models with
a dichotomous response variable, and it provides an estimate of the model’s
ability to discriminate between observed instances of death and survival. A
value of 0.5 indicates that the model provides predictive discrimination
equal to chance, whereas a value of 1.0 indicates perfect discrimination
between dependent outcomes. The Nagelkerke PseudoR2 statistic is a
log-likelihood ratio c2 based measure that is analogous to the R2 statistic
in ordinary multiple regression. The Nagelkerke PseudoR2 statistic theoret-
ically changes from 0 for models that provide no predictive information to
1 for models that predict perfectly. Model calibration was assessed using
the Hosmer-Lemeshow c2 test statistic. All statistical analyses were con-
ducted using R statistical software, version 2.12.1 (R Foundation for Statis-
tical Computing, Vienna, Austria).
RESULTS
Patient Characteristics and Operative Features for
Primary, Isolated CABG
Table 1 displays descriptive statistics and frequencies for
select patient risk factors used to derive the STS PROM
score for isolated CABG operations. For the entire patient
cohort, operative mortality following primary, isolated2688 The Journal of Thoracic and Cardiovascular SurCABG operations was 1.9% and overall median STS
PROM was 1.1%. Overall median individual surgeon vol-
ume over the entire study period was 544 operations, with
the highest volume surgeons (95th percentile) performing
a median of 1434 isolated CABG operations. Similar distri-
butions in overall cardiac surgical volumes were apparent
for individual surgeons, suggesting that isolated CABG vol-
umes correlated with overall surgeon volume during this
study period. Average patient age was 63.9 years, and the
large majority of patients (73%) were men. Diabetes was
the most prevalent comorbid disease, occurring in 39% of
patients. With respect to preoperative cardiac status, a ma-
jority of patients presented with New York Heart Associa-
tion functional class II or III, underwent myocardialgery c December 2014
FIGURE 1. Histograms displaying the distribution of Society of Thoracic Surgeons predicted risk of mortality (STS PROM). A, Overall STS PROM
distribution. B, STS PROM 0% to 10%. C, STS PROM 10% to 25%. D, STS PROM 25% to 50%.
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Drevascularization for 2-vessel coronary artery disease, and
underwent operations in either an elective or urgent setting.
Adjusted Relationship Between Probability of Death
and Estimated Mortality Risk
To identify a potential patient population in whom a 1%
CABG mortality rate may be achievable, the relationship
between observedmortality and estimatedmortality risk us-
ing the STS PROM score was explored. Figure 1 displays
the overall distribution of STS PROM scores for the entire
patient population (Figure 1, A), those with scores ranging
from 0% to 10% (Figure 1, B), those with scores ranging
from 10% to 25% (Figure 1, C), and those with scores
>25% (Figure 1, D). As expected, STS PROM scores
were nonnormally distributed with a prominent right ward
skew in the distribution of scores. Considering these find-
ings, operative mortality was modeled as a function of
STS PROM with RCS transformations as both linear and
nonlinear terms, adjusted for the confounding influence ofThe Journal of Thoracic and Carindividual surgeon volume (with RCS transformations)
and operative year (Table 2). As a result, the association be-
tween STS PROM and operative mortality was highly sig-
nificant (P< .0001) (Figure 2, A). More importantly, the
adjusted spline function revealed that an STS PROM
threshold value of 1.27% correlated with a 1.0% probabil-
ity of death (Figure 2, B), which accounted for 57%
(n¼ 19,720) of the total study population. Further examina-
tion of this relationship revealed that the STS PROM
demonstrated a limited predictive capacity for operative
mortality for STS PROM>25% because the relationship
between expected mortality and the probability of death
began to diverge with widening confidence intervals.
The statistical performance of this regression model
achieved adequate discrimination with a C statistic ¼
0.81. The model explained 16% of the variance in operative
mortality as reflected by a Nagelkerke PseudoR2 value of
0.16. Model calibration was adequate across deciles of
observed risk as reflected by Hosmer-Lemeshow P<.05.diovascular Surgery c Volume 148, Number 6 2689
TABLE 2. Multivariable logistic regression results for operative
mortality modeled as a function of Society of Thoracic Surgeons
predicted risk of mortality (STS PROM) (with restricted cubic
splines), surgeon operative volume (with restricted cubic splines),
and operative year.* Ranked by covariate likelihood ratio (Wald c2
test statistic)
Covariate
Likelihood
ratio (Wald c2)
Odds ratio
(95% confidence
interval) P value
STS PROM (linear) 846.7 1.89 (1.68-2.09) <.0001
STS PROM (nonlinear) 251.5 6.59 (5.35-8.12) <.0001
Operative year
(reference ¼ 2005)
46.3 <.0001
2001 0.38 (0.15-0.96)
2002 0.92 (0.55-1.53)
2003 1.15 (0.72-1.83)
2004 0.72 (0.49-1.07)
2006 0.92 (0.67-1.28)
2007 0.90 (0.65-1.24)
2008 1.43 (1.04-1.97)
2009 1.79 (1.32-2.43)
2010 1.46 (1.06-2.01)
2011 1.27 (0.90-1.78)
2012 1.34 (0.75-2.39)
Surgeon operative
volume (linear)
16.3 0.31 (0.47-0.15) .0003
Surgeon operative
volume (nonlinear)
0.8 0.73 (0.62-0.86) .36
STS PROM, Society of Thoracic Surgeons predicted risk of mortality. *Model
performance characteristics: C statistic ¼ 0.81, Nagelkerke PseduoR2 ¼ 0.16.
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STS PROM Threshold
After empirically testing the adjusted relationship between
operativemortality and STS PROM, a threshold value of STS
PROM 1.27% correlatedwith a desired goal of1% oper-
ative morality. Thus, to further characterize patient risk pro-
files for those projected to achieve goal mortality compared
with those who were not, the frequency of patient and opera-
tive risk factors were stratified into STS PROM categories:
STS PROM  1.27% and STS PROM>1.27% (Table 3).
Median STS PROM scores for both cohorts were 0.7% and
2.4%, respectively. Not surprisingly, patients with STS
PROM>1.27% were older with a higher burden of comor-
bid disease, reduced cardiac function, an increased burden of
coronary artery disease, and more frequent nonelective oper-
ations. Mortality was significantly higher in those with STS
PROM>1.27% (3.7% vs 0.6%; P<.001).
Next, the adjusted relationship between operative moral-
ity and patient risk factors and established processes of care
was modeled for each STS PROM patient cohort to identify
potential patient- and operation-related factors to explain
differences in mortality risk. Table 4 displays the relative
strength of association between modeled factors and mor-
tality as determined by comparing the likelihood ratios
(Wald c2). Figure 3 displays dot plots depicting the relative2690 The Journal of Thoracic and Cardiovascular Surpredictive capacity of each modeled factor for the outcome
of operative mortality among STS PROM study cohorts.
Among both cohorts process of care measures such as peri-
operative medication use and cardiac protective medication
at discharge were among factors with the strongest associa-
tion with mortality risk. Similarly, potentially modifiable
factors such as heart failure, preoperative renal function,
and cerebrovascular disease had significant associations
with mortality. Not surprisingly, in the cohort of patients
with STS PROM> 1.27%, intra-aortic balloon pump use
and previous PCI demonstrated significant relationships
with mortality, whereas these factors were not associated
with mortality in patients with STS PROM<1.27%Model
performance within each study cohort was strong with
respect to discrimination (C statistic ¼ 0.91 and 0.94),
explanation of variance (Nagelkerke PseudoR2 ¼ 0.16),
and calibration (Hosmer-Lemeshow P<.05).
Comparison of Patient Risk Profiles and Factors
Between Survivors and Decedents in Patients Above
the STS PROM Threshold
Patient risk profiles were compared between survivors
and decedents in the cohort of patients with STS PROM
scores above the 1.27% threshold to aid in clinical decision
making for those where 1% observed mortality is not pro-
jected to be achievable (Table 5). In this cohort of patients,
decedents expectedly presented with higher preoperative
risk and significantly higher median STS PROM scores,
were on average older, were likely to be women, and had
much higher rates of hemodialysis, peripheral vascular dis-
ease, heart failure, advanced New York Heart Association
functional class, and emergent operations. Median individ-
ual surgeon volume was significantly lower for decedents
compared with survivors. Significant differences in the pro-
vision of cardiovascular medications at discharge were dra-
matic between overall survivors and decedents after
discharge. Interestingly, no significant differences were
observed with respect to preoperative beta-blocker use.
DISCUSSION
Our study reports on current trends in primary, isolated
CABG mortality in a large, multi-institutional statewide
cohort of patients with a focus of determining whether or
not the challenge to achieve an observed mortality rate of
1% is feasible in the modern surgical era and to identify
in which patients this goal may be achieved. To investigate
this question, the widely accepted and validated STS PROM
score was used to demonstrate a threshold value at which
expected mortality risk and adjusted probability of death
correlate. Patient risk profiles, operative features, and peri-
operative processes of carewere then examined as a function
of this threshold to further identify patient populations
where a 1% goalmortality ratemay not be achievable. Over-
all, these novel findings further clarify the feasibility of thegery c December 2014
FIGURE 2. Plot of adjusted association between operativemortality and (A) overall restricted cubic spline function for Society of Thoracic Surgeons (STS)
predicted risk of mortality and (B) restricted cubic spline function for STS predicted risk of mortality (0%-1.27%).
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CABG and to demonstrate that these goals may be achiev-
able in select patient populations. Further, these results high-
light several important implications related to CABG
quality assessment and reporting as well as surgical perfor-
mance standards and process of care.
The principle purpose of our study was to determine if the
challenge to achieve a1% operative mortality rate for pri-
mary, isolated CABG is feasible in the modern surgical era.
A reduction in CABG mortality over the past several years
has been reported by the STS in several nationwide se-
ries.1,2,11 In a recent report of national trends in STS
CABG outcomes among 1.49 million patients from 2000
to 2009, predicted mortality rates of 2.3% were consistent
over the study period, whereas observed mortality rates
declined from 2.4% to 1.9%, representing a 24%
reduction in relative risk for the performance of CABG
over a 10-year period.1 Considering these trends and that
the STS PROM score has been developed and widely
accepted as a method of determining surgical risk, our
report empirically tested the correlation of STS PROM
with adjusted probability of death, taking into account the
confounding influence of individual surgeon volume and
hospital as well generalized changes in practice pattern
over operative years. Our results demonstrate a highly
significant association between STS PROM and adjusted
probability of death. More importantly, using RCS trans-
formations of the STS PROM function, we demonstra-
ted an important threshold value of STS PROM
(PROM ¼ 1.27%) where the adjusted probability of death
following CABG could be expected to be 1%. Consid-
ering this threshold, the proportion of patients represented
in this statewide, multi-institutional patient cohort with
STS PROM  1.27% accounted for 57% of the total study
population and demonstrated an observed operative mortal-
ity rate of 0.6%. These findings may be extrapolated to sug-
gest that the challenge to achieve 1% operative mortalityThe Journal of Thoracic and Carfor primary, isolated CABG may be feasible in less than
two-thirds of patients requiring surgical myocardial
revascularization.
The second purpose of our study was to identify in which
patient populations a 1% operative mortality goal is
achievable relative to the estimated operative risk. To
answer this question, the established threshold value for
STS PROMwas used to stratify the study cohort to compare
patient risk profiles, operative features, and the role of es-
tablished perioperative processes of care. Next, all 30 com-
ponents of the STS PROM score as well as STS and
National Quality Forum-approved measures of perfor-
mance were modeled to determine their relative importance
in the prediction of CABG-related mortality. The reported
findings demonstrate that those patients in whom goal mor-
tality can be achieved are on average significantly younger,
more commonly men, present with a reduced burden of co-
morbid disease and with superior cardiac function, and un-
dergo significantly fewer emergent operations. Perhaps
more significant than these findings were the demonstrated
differences in the relative strength of the association among
modeled patient risk factors and adjusted mortality risk
within each study cohort. Unique in our analyses was the
demonstration that within the patient cohort in which goal
mortality was deemed not achievable (ie, STS PROM
> 1.27%) the relative strength of association between
certain risk factors and mortality was much higher than in
the cohort in which goal mortality was deemed achievable
(ie, STS PROM  1.27%). Thus, although in both cohorts
of patients (STS PROM  1.27% and>1.27%) process of
care measures, including the provision of aspirin and beta-
blockers at the time of discharge, were the strongest predic-
tors ofmortality, themodeled effect sizes or likelihood ratios
within the STSPROM>1.27% cohort (Wald statistic¼ 282
and 133, respectively)were significantly higher than those in
the STS PROM 1.27% cohort (Wald statistic¼ 57 and 29,
respectively). These results imply that there existsdiovascular Surgery c Volume 148, Number 6 2691
TABLE 3. Comparison of select patient risk factors and processes of
care by Society of Thoracic Surgeons predicted risk of mortality
(STS PROM) threshold
Variable
STS PROM
 1.27%
STS PROM
>1.27% P value
Median STS PROM,% 0.7 (0.5, 0.9) 2.4 (1.7, 4.0) <.001
Age, y 59.0  8.7 70.5  9.4 <.001
Gender <.001
Male 82.7 60.6
Female 17.3 39.4
Weight, kg 90 (79, 102) 81 (70, 93) <.001
Height, cm 175 (168, 180) 170 (163, 178) <.001
Diabetes 34.9 45.4 <.001
Dialysis 0.1 5.5 <.001
Chronic lung disease <.001
Mild 7.6 13.1
Moderate 2.9 8.2
Severe 0.8 4.8
Immunosuppression 0.8 3.6 <.001
Peripheral vascular disease 7.0 24.2 <.001
Cerebrovascular disease 6.7 22.5 <.001
Cerebrovascular accident 2.3 10.0 <.001
Myocardial infarction 15.4 30.8 <.001
Heart failure 4.6 21.6 <.001
New York Heart Association
functional class
<.001
I 8.8 6.6
II 34.5 21.9
III 46.3 45.2
IV 10.4 26.3
Atrial fibrillation 1.8 7.1 <.001
Number of diseased vessels <.001
One 5.3 2.5
Two 20.3 14.6
Three 74.1 82.8
Ejection fraction,% 55 (50, 60) 50 (40, 60) <.001
Status <.001
Elective 46.5 32.3
Urgent 53.1 60.0
Emergent 0.4 7.7
Median surgeon volume 530 (293, 848) 582 (317, 930) <.001
Operative mortality 0.6 3.7 <.001
Beta-blocker (preoperative) 84.0 81.0 <.001
Beta-blocker (discharge) 91.7 83.2 <.001
Antiplatelet (discharge) 96.5 91.6 <.001
Lipid-lowering medication
(discharge)
92.1 82.1 <.001
Values are given as median (25th, 75th percentile), mean standard deviation, or%.
STS PROM, Society of Thoracic Surgeons predicted risk of mortality.
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ity through improved efforts to modify practice patterns and
optimize perioperative cardiac surgical care.
The third purpose of our study was to identify the patient-
and operation-related risk factors that contribute most to
mortality among patients where goal mortality was deemed
not achievable. This was done to discern if certain patients2692 The Journal of Thoracic and Cardiovascular Surshould not be receiving surgical myocardial revasculariza-
tion. The results of these analyses reveal striking differences
in patient risk profiles for survivors and decedents in this
cohort of patients. Among this seemingly high-risk patient
population, the most striking differences between survivors
and decedents occurred as a function of estimated mortality
risk; individual surgeon operative volume; and in the prev-
alence of preoperative hemodialysis requirements, preoper-
ative heart failure, and performance of emergent versus
nonemergent operations. Specifically, this result suggests
that patients and surgeons should be particularly aware of
the increased risk of performing isolated CABG operations
in patients with STS PROM>4.6%, patients with preoper-
ative hemodialysis requirements, and patients with poor
preoperative cardiac function. More importantly, these find-
ings support the argument that surgeons performing CABG
operations for these select patients should not be penalized
for disproportionately high mortality rates compared with
patients with lower risk profiles.
Critical to the reported results in our study are themethods
used to analyze the relationship between the STS PROM
score and adjusted probability of death as well as the results
of these analyses. In our analyses the choice to model mor-
tality as function of STS PROM was a result of several fac-
tors. STS PROM has become a validated and widely
accepted tool used by surgeons to identify and predict mor-
tality risk for individual patients. As a result, we wanted to
not only quantify the number of patients in Virginia
achieving a 1%mortality, but also to verify and demonstrate
the reliability of using STS PROM in the future to help pre-
dict the potential to achieve this goal. The use of RCS trans-
formations of the STS PROM variable is the most accurate
and robust approach to modeling this continuous function
because it characterizes the linear and nonlinear components
that may exist between the relationship between STS PROM
and operative mortality.12,13 A common approach used in
the cardiac surgery literature is the seemingly arbitrary
categorization of STS PROM into discrete categories (ie,
quartiles or quintiles).9,14,15 This approach presents an
inherent methodologic problem as the conversion of
continuous data, such as STS PROM, into categorical data
results in a crucial loss of information.12 The segmentation
of continuous data is problematic because it discards infor-
mation in the original variable and requires arbitrarily
selected cut points for defining categories and deriving con-
clusions,16 ultimately resulting in a loss of explanatory po-
wer as the modeled effect of that variable is flat across the
range of values included in that category. Thus, if one cate-
gorizes STS PROM for CABG into a category that includes
scores ranging from 0% to 1.5%, the resultant measure of
association will be interpreted as the measure for the entire
range of values included in that category. Thus, a distinction
in mortality for STS PROM of 0.5% compared with STS
PROMof 1.3% could not be drawn. The results of our seriesgery c December 2014
TABLE 4. Comparison of modeled factors for operative mortality ranked by factor likelihood ratio
Model 1: STS PROM  1.27% Model 2: STS PROM>1.27%
Modeled factor Likelihood ratio P value Modeled factor Likelihood ratio P value
ASA (discharge) 57.162 .000 ASA (discharge) 282.740 .000
Beta-blockers (discharge) 29.577 .000 Beta-blockers (discharge) 133.420 .000
Heart failure 20.166 .000 Lipid-lowering drug
(discharge)
60.160 .000
Lipid-lowering drug
(discharge)
17.655 .000 Patient age, y 22.877 .000
Preoperative creatinine level 12.034 .001 Heart failure 15.296 .000
Cardiovascular disease 11.206 .001 Surgeon volume 12.792 .000
New York Heart Association
functional class
10.556 .014 Intra-aortic balloon pump 11.652 .001
Patient age, y 5.729 .017 Previous percutaneous
coronary intervention
9.197 .002
TV insufficiency 5.272 .261 Cardiovascular disease 6.626 .010
Surgeon volume 4.512 .034 Beta-blockers (preoperative) 6.442 .011
ADP inhibitors 4.270 .039 Stroke 5.456 .019
Beta-blockers (preoperative) 3.177 .075 Diabetes mellitus control 4.647 .200
Diabetes mellitus control 2.986 .394 Timing of myocardial
infarction
3.826 .575
IMA use 2.657 .448 TV insufficiency 3.722 .445
AV insufficiency 2.343 .673 Chronic lung disease 3.679 .298
Chronic lung disease 2.019 .568 ADP inhibitors 3.578 .059
MV insufficiency 1.941 .747 Peripheral artery disease 3.355 .067
Race 1.555 .907 Race 2.931 .711
Number of diseased vessels 1.104 .576 Immunosuppression 1.946 .163
Previous percutaneous
coronary intervention
1.013 .314 Hemodialysis 1.817 .178
Diabetes mellitus .857 .355 MV insufficiency 1.539 .820
Timing of myocardial
infarction
.848 .974 New York Heart Association
functional class
1.424 .700
Stroke .779 .378 AV stenosis .827 .363
Height, cm .767 .381 AV insufficiency .747 .945
Peripheral artery disease .411 .521 IMA use .668 .881
Status .406 .816 Cardiogenic shock .406 .524
Intra-aortic balloon pump .157 .692 Diabetes mellitus .356 .551
Ejection fraction .118 .731 Preoperative creatinine level .243 .622
Weight, kg .096 .756 Gender .195 .658
Gender .025 .874 Ejection fraction .178 .673
Immunosuppression .000 .997 Number of diseased vessels .161 .923
Preoperative inotropes .000 .997 Preoperative inotropes .147 .701
AV stenosis .000 .998 Height, cm .126 .723
Resuscitation .000 .998 Resuscitation .054 .816
MV stenosis .000 .999 MV stenosis .039 .843
Previous myocardial
infarction
.000 .999 Status .037 .982
Hemodialysis .000 .999 Weight, kg .003 .958
Cardiogenic shock .000 1.000 Previous myocardial
infarction
.000 .999
STS PROM, Society of Thoracic Surgeons predicted risk of mortality; ASA, American Society of Anesthesiologists; TV, tricuspid valve; ADP, adenosine diphosphate; IMA, in-
ternal mammary artery; AV, aortic valve; MV, mitral valve.
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probability of death between such a range of STS PROM
scores is not only statistically, but also clinically significant
in the context of achieving a goal of1%mortality for iso-
lated CABG. Furthermore, the observation in our study thatThe Journal of Thoracic and CarSTS PROM scores>25% do not appear to correlate well
with the probability of death after adjustment for operative
year and surgeon volume highlights an apparent limitation
of the STS PROM score for very–high-risk patients under-
going isolated CABG operations that surgeons should bediovascular Surgery c Volume 148, Number 6 2693
FIGURE 3. Dot plots of likelihood ratios (Wald statistics) for each modeled factor as it relates to the probability of death for patients with (A) Society of
Thoracic Surgeons predicted risk of mortality1.27% and (B) Society of Thoracic Surgeons predicted risk of mortality>1.27%. ASA, American Society of
Anesthesiologists; CVD, cardiovascular disease; NYHA, New York Heart Association; TV, tricuspid valve; ADP, adenosine diphosphate; DM, diabetes mel-
litus; IMA, internal mammary artery; AV, aortic valve;MV, mitral valve; PCI, percutaneous coronary intervention;MI, myocardial infarction; PAD, periph-
eral arterial disease; IABP, intra-aortic balloon pump; EF, ejection fraction.
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Daware of during preoperative patient counseling and risk
assessment.
Our results have significant surgeon- and health care
system-related implications. In the current health care envi-
ronment, many different organizations have become
increasingly focused on risk-adjusted outcome reporting
and the use of various metrics by which to rank hospitals
and providers from a quality performance perspective.
Thus, health insurance groups and organizations such as
The Leapfrog Group, the National Quality Forum, and the
Agency for Healthcare Research and Quality are attracted
to easily measurable and identifiable metrics that can be
used to base referral patterns and regionalization of medical
care. With this in mind, the ambitious goal to achieve a
1% observed mortality rate for isolated CABG operations
may require significant qualification based on the results of
our analyses to help guide such groups in the very near
future. The fear that generalized adoption of a1%mortal-
ity rate for the performance of all isolated CABG operations
could become a metric by which current and future genera-
tions of cardiothoracic surgeons could be held accountable
leaves very little room for surgical error and creates an
inhospitable environment for new surgeons and surgeons
or hospitals that routinely perform operations on high risk
CABG patients where the likelihood of achieving an
average mortality rate of 1% is unlikely. Nevertheless,
surgeons will undoubtedly be presented with higher-risk pa-
tients in whom a 1% operative mortality will be very diffi-
cult to achieve but who will nonetheless have a better
overall survival with the operation than with alternative
forms of treatment, which questions the need to compete
with PCI with respect to short-term, periprocedural2694 The Journal of Thoracic and Cardiovascular Surmortality. There are also ultra–high-risk patients who may
be better candidates for PCI. With this in mind, the develop-
ment of a surgeon and/or hospital quality index may be
beneficial to take into account variations in patient risk pro-
files for the performance of isolated CABG operations.
Calculated observed to expected ratios are an alternative
metric of performance for surgeons and hospitals. We
believe that modeling mortality risk while taking into ac-
count factors such as surgeon experience (using volume
as a surrogate), differences between hospitals, and inherent
changes in practice pattern over time provide further insight
into the use of commonly available and routinely used clin-
ical tools such as the STS PROM calculator when deter-
mining patient mortality risk and assessing surgeon- and
hospital-specific quality for the performance of CABG.
The role that various processes of care play in the context
of our results deserves special attention. The STS and Na-
tional Quality Forum have identified several different per-
formance measures and processes of care for the
performance of isolated CABG operations.17,18 The
multidimensional performance measure is composed of 4
different domains consisting of 11 different operative and
perioperative cardiac surgery metrics, including use of
internal mammary artery grafts and perioperative
medication use such as beta-blockers, antiplatelet medica-
tions, and lipid-lowering agents. Thus, in the context of
our report, the role of these factors as determinants in the
achievement of 1% operative mortality is of critical
importance. The results of our analyses demonstrate that
among modeled factors for adjusted probability of death,
the provision of perioperative medications plays a dispro-
portionate role and that an increase in use of these processesgery c December 2014
TABLE 5. Comparison of select patient risk factors and processes of
care between survivors and decedents for patients with Society of
Thoracic Surgeons predicted risk of mortality (STS PROM)>1.27%
Variable
Survivors
(n ¼ 14,138)
Decedents
(n ¼ 549) P value
STS PROM,% 2.4 (1.7, 3.9) 4.6 (2.7, 9.2) <.001
Age, y 70.4  9.5 72.3  9.4 <.001
Gender .08
Male 60.8 57.0
Female 39.2 43.0
Weight, kg 81 (70, 92) 80 (67, 92) .05
Height, cm 170 (163, 178) 168 (160, 178) .02
Diabetes 45.4 45.5 .93
Dialysis 5.3 11.3 <.001
Chronic lung disease <.001
Mild 13.1 12.0
Moderate 8.2 9.5
Severe 4.6 9.8
Immunosuppression 3.5 5.8 .005
Peripheral vascular disease 23.9 32.1 <.001
Cerebrovascular disease 22.4 26.2 .04
Cerebrovascular accident 9.9 10.2 .83
Myocardial infarction 30.9 29.7 .57
Heart failure 21.0 37.3 <.001
New York Heart Association
functional class
<.001
I 6.7 3.3
II 22.1 16.5
III 45.4 38.6
IV 25.7 41.6
Atrial fibrillation 6.9 11.1 <.001
Number of diseased vessels .68
One 2.5 2.4
Two 14.5 16.6
Three 82.9 80.9
Ejection fraction,% 50 (40, 60) 45 (30, 55) <.001
Status <.001
Elective 32.7 22.2
Urgent 60.0 60.8
Emergent 7.3 16.9
Surgeon volume 582 (319, 930) 464 (266, 739) <.001
Beta-blocker (preoperative) 81.8 77.7 .06
Beta-blocker (discharge) 85.8 19.7 <.001
Antiplatelet (discharge) 94.5 21.1 <.001
Lipid lowering medication
(discharge)
84.7 19.5 <.001
Values are given as median (25th, 75th percentile), mean standard deviation, or%.
STS PROM, Society of Thoracic Surgeons predicted risk of mortality.
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reduce mortality following performance of isolated CABG.
Our results also demonstrate the benefits of statewide and/
or regional cardiac surgery quality initiatives to advance
goals of the cardiothoracic and medical community. Also
highlighted by leadership in the field of cardiothoracic sur-
gery as an essential goal for cardiac surgery,4 regional and
statewide cardiac surgical quality initiative groups play an
important role in helping to define various processes ofThe Journal of Thoracic and Carcare and best practice techniques to affect outcomes and
quality care delivered to patients undergoing cardiac sur-
gery. As a result, an important aspect of our study concerned
the statewide collaborative effort of the VCSQI to use both
clinical and uniform patient-specific financial data to help
identify evidence-based best practice models with the goal
of improving cardiac surgery outcomes while reducing
costs. Through the process of examining the relative effects
of various outcomes on cardiac surgical costs and resource
use, we have been able to advance several different initia-
tives aimed to improve overall surgical quality within the
Commonwealth of Virginia, including protocols designed
to address the negative effect of atrial fibrillation and blood
product use.19 The results of our study, therefore, set the
stage for the future development of protocol-driven ap-
proaches to reduce complication rates and other identified
factors contributing to operative mortality for the perfor-
mance of primary, isolated CABGoperations within VCSQI
participating centers to achieve lower mortality rates in an
attempt to increase the number of patients where the goal
of 1% operative mortality can be achieved.
Our study has limitations. First, the secondary analysis of
the VCSQI data registry and STS data limited the performed
analyses to de-identified data that are nonrandomized. The
study design is subject to limitations of inherent selection
bias, and the reported results are limited to describe observed
associations between factors and outcomes without assessing
direct cause and effect relationships. Second, the blinded na-
ture of the data further limited the ability to scrutinize certain
surgeon- and hospital-specific details, including differences
in individual surgeon experience (ie, years of practice) or sur-
gical volume as a function of university versus community
hospital environment. As a result, the opportunity to identify
and describe best practice models within participating hospi-
tals is not possible at this time. Third, although the influence
of correlated hospital events was modeled as a random effect
within the performed hierarchical regression models, the
variance attributed to the unique characteristics of partici-
pating VCSQI hospitals cannot fully be accounted for in
our statistical analysis. In addition, all analyses were limited
to short-term, operative outcomes, and intermediate or long-
term follow-up data were not available. Finally, the potential
for unrecognized miscoding of data must also be considered
in any secondary analysis of a data registry.
CONCLUSIONS
Based on reported results, the goal to achieve1% oper-
ative mortality for primary, isolated CABG appears feasible
in appropriately selected patients in the modern surgical era.
However, this goal may be achieved in<60% of CABG pa-
tients without other improvements in processes of care. The
calculated STS PROM score can be used to strongly identify
patients with a threshold value of estimated mortality risk
1.27% to achieve this goal. However, the STS PROMdiovascular Surgery c Volume 148, Number 6 2695
Acquired Cardiovascular Disease LaPar et al
A
C
Dappears limited in its predictive capacity for very–high-risk
patients with estimated risk>25.0%. These data provide a
strong foundation for further study to determine if 1%
mortality for CABG is achievable nationwide.
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Dr Todd Rosengart (Houston, Tex). Congratulations on an
excellent study and thank you for allowing me to see your manu-
script in advance. This is important work and you present very
interesting results.2696 The Journal of Thoracic and Cardiovascular SurOne of the most striking findings of your study is the apparent
implication of the failure to prescribe statins, beta-blockers, and
aspirin before discharge. Dr Ralph Damiano was perhaps the first
to suggest that maybe the greatest priority of an organization such
as American Association of Thoracic Surgery and Society of
Thoracic Surgeons should be to focus on a ‘‘get with the guide-
lines’’ campaign to improve outcomes, similar to the American
Hospital Association program. Based on your analysis, do you
think improvements in the rates of drug administrations would
have affected outcomes?
Dr LaPar.When we modeled out all 30 different variables that
go into calculating the Society of Thoracic Surgeons predicted risk
of mortality score, took into account individual surgeon volume,
and the accepted process of care measures for coronary artery
bypass grafting, we found that beta-blockers, statins, and aspirin
actually had the highest strength of association with predicted
mortality rate in both of our cohorts and, in fact, that strength of
association was significantly stronger in the cohort of patients
with higher risk. So absolutely process of care measures are some-
thing we need to focus on if we are going to attempt achieving the
<1% mortality goal in all of our efforts to reduce mortality related
to coronary artery bypass grafting.
Dr Rosengart. Although the ambitious goal of<1% mortality
across the board is certainly admirable, it would be difficult to
expect that patients with predicted mortality of 25% or higher
where even the predicted risk of mortality analysis becomes unpre-
dictive of outcome could be taken care of with<1%mortality. You
mentioned that 60% of a target population might be appropriate for
a targeted 1% mortality outcome, but will you comment further on
those highest-risk patients? What percentage of the population
were they and what were the implications of accepting the fact
that these clearly are not patients who can undergo surgery due
to their low expected mortality rates?
Dr LaPar. I think that is an essential point. One of the things
we were concerned about initially was exactly how many patients
were actually going to be able to achieve this end point, because a
number of institutions within our quality initiative (as well as many
represented here) do in fact operate on patients who are at signif-
icantly higher risk. That has notable policy implications. We need
to be very careful that we do not set ourselves up to have hospitals
referring more and more patients with higher risk to some of the
institutions represented in our analysis while we are charged
with trying to achieve a very low mortality rate. It may not be
achievable in those patients.
Dr Rosengart. I was hoping you could comment further
on the implications of surgeon and institution case volume.
It clearly was not as significant a factor as drug administration,
but did you do any further subanalyses to look at the im-
plication?
Dr LaPar. We did not do any specific subgroup analyses
looking at surgeon volume. We did demonstrate a significant rela-
tionship between surgeon and institution volume. We included a
smoothing function and we believe that surgeon experience and
surgeon volume clearly are important.
It would be interesting to look at surgeon experience over
time—because surgeons get better as they advance through their
careers—to see where that correlates with predicted risk and these
goals. We plan to look at that in the future.gery c December 2014
